Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin H Wintermute

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|July 7, 2022
Low-cost anti-mycobacterial drug discovery using engineered E. coliNadine Bongaerts, Zainab Edoo, Ayan A Abukar, et al.
ACS Synthetic Biology|December 20, 2014
Silencing of antibiotic resistance in E. coli with engineered phage bearing small regulatory RNAsVincent K Libis, Aude G Bernheim, Clovis Basier, et al.
ACS Synthetic Biology|November 20, 2014
In situ characterization of mycobacterial growth inhibition by lytic enzymes expressed in vectorized E. coliIva Atanaskovic, Amel Camélia Bencherif, Matthew Deyell, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|July 7, 2022
Low-cost anti-mycobacterial drug discovery using engineered E. coliNadine Bongaerts, Zainab Edoo, Ayan A Abukar, et al.
ACS Synthetic Biology|December 20, 2014
Silencing of antibiotic resistance in E. coli with engineered phage bearing small regulatory RNAsVincent K Libis, Aude G Bernheim, Clovis Basier, et al.
ACS Synthetic Biology|November 20, 2014
In situ characterization of mycobacterial growth inhibition by lytic enzymes expressed in vectorized E. coliIva Atanaskovic, Amel Camélia Bencherif, Matthew Deyell, et al.
Pageof 2